Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience.
Saved in:
| Title: | Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real-life experience. |
|---|---|
| Authors: | Esme P; Department of Dermatology and Venereology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Akoglu G; Department of Dermatology and Venereology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Dalkıran CD; Department of Dermatology and Venereology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey., Caliskan E; Department of Dermatology and Venereology, Gulhane Training and Research Hospital, University of Health Sciences, Ankara, Turkey. |
| Source: | Dermatologic therapy [Dermatol Ther] 2022 Nov; Vol. 35 (11), pp. e15782. Date of Electronic Publication: 2022 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 9700070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-8019 (Electronic) Linking ISSN: 13960296 NLM ISO Abbreviation: Dermatol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1529-8019 |
|---|---|
| DOI: | 10.1111/dth.15782 |
